Bioxcel Therapeutics Logo

ABOUT

BioXcel Therapeutics, Inc. is a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience. The company’s wholly owned, clinical-stage subsidiary, OnkosXcel Therapeutics, is focused on developing medicines in immuno-oncology.

Innovating Medicine by Leveraging Artificial Intelligence

Vertical AI Inset
We are focused on utilizing cutting-edge technology and innovative research to develop high-value therapeutics aimed at transforming patients’ lives. BioXcel Therapeutics employs a unique AI platform to reduce therapeutic development costs and potentially accelerate timelines while aiming to increase the possibility of success.

Innovating Medicine by Leveraging Artificial Intelligence

We are focused on utilizing cutting-edge technology and innovative research to develop high-value therapeutics aimed at transforming patients’ lives. BioXcel Therapeutics employs a unique AI platform to reduce therapeutic development costs and potentially accelerate timelines while aiming to increase the possibility of success.

Our approach leverages existing approved drugs and/or clinically evaluated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indications. We believe that this differentiated approach has the potential to reduce the expense and time associated with drug development in diseases with substantial unmet medical needs.

Therapeutic Area Focus

Targeting neuroscience disorders with significant unmet medical needs and large market opportunities

Drug Re-Innovation

Our proprietary drug development approach aims to leverage existing approved drugs and/or clinically evaluated product candidates

Higher Probability of Success

Developing first-in-class drug candidates while aiming for a higher probability of clinical and regulatory success

Therapeutic Benefit

Potential to provide clinical benefit to patients in need

Our Differentiated Approach

Our Differentiated Approach

Therapeutic Area Focus

Targeting neuroscience disorders and immuno-oncology with significant unmet medical need and large market opportunity

Drug Re-Innovation

The proprietary drug development approach aims to leverage existing approved drugs and/or clinically evaluated product candidates

Higher Probability of Success

Developing first-in-class drug candidates while aiming for a higher probability of clinical and regulatory success

Therapeutic Benefit

Potential to provide clinical benefit to patients in need

Circle line icon
Scroll to Top

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries. This web site is intended to help healthcare professionals practicing in the US find scientifically balanced, evidence-based information about Bioxcel Therapeutics drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.